Loading...
Phase I and pharmacologic study of BNP7787, a novel chemoprotector in patients with advanced non-small cell lung cancer
PURPOSE: We conducted a phase I trial of BNP7787 (disodium 2,2′-dithio-bis-ethane sulfonate, Tavocept™), a novel chemoprotective and antitumor enhancing agent administered in combination with paclitaxel and cisplatin. The primary aim was to determine a safe and potentially efficacious BNP7787 dose f...
Na minha lista:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer-Verlag
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3043260/ https://ncbi.nlm.nih.gov/pubmed/20473611 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-010-1340-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|